<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02352220</url>
  </required_header>
  <id_info>
    <org_study_id>PI13-02225</org_study_id>
    <nct_id>NCT02352220</nct_id>
  </id_info>
  <brief_title>Determinants of Onset and Progression of COPD in Young Adults</brief_title>
  <acronym>EARLY COPD</acronym>
  <official_title>Early COPD: Determinants of Onset and Progression of COPD in Young Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Borja Cosio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Spanish Research Center for Respiratory Diseases</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Son Espases</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital del Mar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario 12 de Octubre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Parc Taulí, Sabadell</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospitales Universitarios Virgen del Rocío</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitari de Bellvitge</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Arnau de Vilanova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario Central de Asturias</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital of the Nuestra Señora de Candelaria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital A Coruña</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Barcelona Institute for Global Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Son Espases</source>
  <brief_summary>
    <textblock>
      COPD (Chronic Obstructive Pulmonary Disease) is a Public Health problem due to its impact in
      the patient's quality of life, high prevalence, growing incidence and socioeconomic
      implication. COPD natural history and first stages determinants are unknown. Knowing them
      will help to understand the natural history of the disease and to design interventions that
      can modify the prognosis of the disease.

      Study objectives: (1) To characterize an early COPD population from a multidimensional point
      of view including demographic, social, family and clinical data, lung function, exercise
      capacity, image, microbiology, quality of life, exacerbations, comorbidities and blood and
      sputum biomarkers. (2) To compare this patients with smoking subjects, with normal lung
      function, matched by age, sex and site. (3) To create an early COPD cohort to be followed in
      the future to understand the complete natural history of the disease.

      Methods: Design: multicenter cross-sectional study that will allow establishing a
      well-characterized cohort of early COPD patients for later follow-up. Recruitment will be
      done in Primary Care settings. Subjects: smokers (&gt; 10 packs year) between 35-50 years old
      with a spirometry (normal or obstructive) done in the last year. Diagnosis of COPD will be
      based on the smoking history and a postbronchodilator test FEV1(Forced Expiratory Volume in
      the first second) / FVC(Forced Vital Capacity) &lt; 70%. Age, sex and site matched 'healthy'
      smoker controls will be compared with the COPD cases. Variables that will be collected in the
      reference hospitals are: health questionnaires, lung function test, exercise capacity, blood
      and sputum samples, and low dose CT-scan. Statistical analysis: early COPD patient's
      characteristics will be described and then, will be compared, with control subjects through a
      conditional multiple logistic regression analysis.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in lung function measures between cases and controls</measure>
    <time_frame>At time of visit 1 (cross-sectional)</time_frame>
  </primary_outcome>
  <enrollment type="Actual">310</enrollment>
  <condition>COPD</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Smokers from 35 to 50 years who ever performed a spirometry in the selected primary care
        centers. Selected subjects will not have exacerbation symptoms (fever, new onset or
        increased cough, increase sputum volume and/or purulence, acute rhinitis) within 8 weeks
        prior to the recruitment (from beginning of the symptoms).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        **Inclusion Criteria:

        COPD case:

          -  Subjects between 35 and 50 years

          -  Post-bronchodilator spirometry with FEV1/FVC &lt;70%

          -  Smoker or ex-smoker with total cumulative exposure &gt; 10 pack-years

        Smoking control:

          -  Subjects between 35 and 50 years

          -  Post-bronchodilator spirometry with FEV1/FVC &gt;=70%

          -  Smoker or ex-smoker with total cumulative exposure&gt; 10 pack-years

               -  Exclusion Criteria:

        For cases:

          -  Chronic inflammatory diseases including autoimmune diseases under treatment.

          -  HIV

          -  Active cancer

          -  Cystic or saccular bronchiectasis

          -  Conditions that may interfere with follow-up: frequent change of residence,
             psychiatric disorders, dementia…

        For controls:

          -  Chronic inflammatory diseases including autoimmune diseases under treatment

          -  HIV

          -  Active cancer

          -  Chronic respiratory diseases:

          -  active tuberculosis

          -  interstitial lung diseases

          -  cystic or saccular bronchiectasis

          -  ever diagnosed asthma

          -  deficit of alpha1-antitrypsin

          -  Conditions that may interfere with follow-up: frequent change of residence,
             psychiatric disorders, dementia …
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Borja Cosio, Medical Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spanish Research Center for Respiratory Diseases</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Son Espases</name>
      <address>
        <city>Palma Mallorca</city>
        <state>Mallorca</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2014</study_first_submitted>
  <study_first_submitted_qc>January 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2015</study_first_posted>
  <last_update_submitted>February 24, 2018</last_update_submitted>
  <last_update_submitted_qc>February 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Son Espases</investigator_affiliation>
    <investigator_full_name>Borja Cosio</investigator_full_name>
    <investigator_title>Dr Fco. de Borja García-Cosío Piqueras</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

